Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Year-over-year book value per share growth
Percentile
P38
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -13.65% |
| Q3 2025 | 5.99% |
| Q2 2025 | 43.85% |
| Q1 2025 | 43.78% |
| Q4 2024 | 24.96% |
| Q3 2024 | 32.81% |
| Q2 2024 | -3.24% |
| Q1 2024 | 23.80% |
| Q4 2023 | -92.06% |
| Q3 2023 | -773.68% |
| Q2 2023 | -88.65% |
| Q1 2023 | -49.10% |
| Q4 2022 | -32.81% |
| Q3 2022 | -27.21% |
| Q2 2022 | 12.70% |
| Q1 2022 | -22.42% |
| Q4 2021 | -13.36% |
| Q3 2021 | -7.97% |
| Q2 2021 | -17.48% |
| Q1 2021 | -19.50% |
| Q4 2020 | 24.31% |
| Q3 2020 | -22.24% |
| Q2 2020 | 35.74% |
| Q1 2020 | -18.09% |
| Q4 2019 | -13.03% |
| Q3 2019 | 15.89% |
| Q2 2019 | -18.72% |
| Q1 2019 | -16.84% |
| Q4 2018 | -16.61% |
| Q3 2018 | -12.94% |
| Q2 2018 | -8.07% |
| Q1 2018 | 91.14% |
| Q4 2017 | -14.14% |
| Q3 2017 | -10.62% |
| Q2 2017 | -5.76% |
| Q1 2017 | -8.57% |
| Q4 2016 | -6.46% |
| Q3 2016 | -7.35% |
| Q2 2016 | -4.88% |
| Q1 2016 | -4.01% |